Telehealth companies offer lifestyle support so people taking obesity drugs can have the most success losing weight. But employers also want the telehealth providers to limit spending on the drugs.
David Davis, a power plant worker in Aptos, Calif., was prescribed GLP-1 medication to treat obstructive sleep apnea. To approve the prescription, his insurance company required him to use Vida Health, an online telehealth company.
Lisa Wiseman for NPR/
hide caption
toggle caption
Lisa Wiseman for NPR/
Drugmakers race to find a place in the next wave of obesity drugs
Trouble Ahead For GLP-1 Drugs As Health Plans Stop Paying
Pharmalittle: We're reading about employer coverage of obesity drugs, another Sanofi setback, and more
Trump’s obesity drug plan creates a temporary Medicare program that may be hard to end
Within 24 hours of injecting the first dose of a weight loss medication she received following a visit with a telehealth doctor,…
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.
Many telehealth companies have emerged in recent years offering easy access to GLP-1 weight loss drugs as demand has exploded.…
Companies have “tremendous concern” about the financial viability of these medications, the president and CEO of the Business…
Employers can use Lilly's platform to connect with different third-party program administrators that help manage obesity…
Drugmakers are betting they can crack into the obesity drug market that Novo Nordisk and Eli Lilly currently dominate.
